SLC7A11 and cancer: Additionally, glucose transporter protein inhibitors could effectively inhibit cellular glucose uptake, causing NADPH depletion, actin cytoskeleton cross-linking, and disulfidptosis in SLC7A11-high cancer cells (10, 11).